Register entry
Orchid Pharma Limited
- Registered sites
- 1
- Drug products
- 5
- Live patents
- 2
- Countries
- 1
- Base
- India
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingPackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Orchid Pharma Limited | ChengalpattuIndia | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3003747558 |
Exclusivity
Patents
2Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| EXBLIFEP | CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM | Dec 2027 |
| EXBLIFEP | CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM | Nov 2034 |
Catalogue
Marketed products
5Showing 5 of 5.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Cefazolin Sodium Sterile Bulk | POWDER | BULK INGREDIENT |
| - | Cefepime Hydrochloride | POWDER | BULK INGREDIENT |
| - | Cefpodoxime Proxetil | POWDER | BULK INGREDIENT |
| - | Ceftiofur Hydrochloride | POWDER | BULK INGREDIENT |
| - | Ceftiofur Sodium | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.